A carregar...
Anti-PEG antibodies inhibit the anticoagulant activity of PEGylated aptamers
Biopharmaceuticals have become increasingly attractive therapeutic agents and are often PEGylated to enhance their pharmacokinetics and reduce their immunogenicity. However, recent human clinical trials have demonstrated that administration of PEGylated compounds can evoke anti-PEG antibodies. Consi...
Na minha lista:
| Publicado no: | Cell Chem Biol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6707742/ https://ncbi.nlm.nih.gov/pubmed/30827937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chembiol.2019.02.001 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|